2020-2029 Report on Global Neurological Biomarkers Market by Player, Region, Type, Application and Sales Channel
- Report Code : MAR1960673
- Published On: Aug, 2020
- Category : Healthcare & Pharma
- Pages : 122
-
The global Neurological Biomarkers market was valued at $XX million in 2019, and Research analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in 2020.
This report analyses the impact of COVID-19 on this industry. COVID-19 can affect the global market in 3 ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on enterprises and financial markets.
This report provides detailed historical analysis of global market for Neurological Biomarkers from 2014-2019, and provides extensive market forecasts from 2020-2029 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Neurological Biomarkers market.
Leading players of Neurological Biomarkers including:
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
Qiagen
Myriad Rbm
Cisbio Bioassays
Athena Diagnostics
Bgi
Wuxi App
Aepodia
Proteome Sciences
Genewiz
Market split by Type, can be divided into:
Proteomics
Genomics
Imaging
Bioinformatics
Others
Market split by Application, can be divided into:
Diagnostics
Drug Discovery
Personalized Medicine
Others
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
-
With tables and figures helping analyze worldwide Report on Global Neurological Biomarkers Market by market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Chapter 1 Neurological Biomarkers Market Overview1.1 Neurological Biomarkers Definition
1.2 Global Neurological Biomarkers Market Size Status and Outlook (2014-2029)
1.3 Global Neurological Biomarkers Market Size Comparison by Region (2014-2029)
1.4 Global Neurological Biomarkers Market Size Comparison by Type (2014-2029)
1.5 Global Neurological Biomarkers Market Size Comparison by Application (2014-2029)
1.6 Global Neurological Biomarkers Market Size Comparison by Sales Channel (2014-2029)
1.7 Neurological Biomarkers Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts on Current Market
1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 Neurological Biomarkers Market Segment Analysis by Player2.1 Global Neurological Biomarkers Sales and Market Share by Player (2017-2019)
2.2 Global Neurological Biomarkers Revenue and Market Share by Player (2017-2019)
2.3 Global Neurological Biomarkers Average Price by Player (2017-2019)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Neurological Biomarkers Market Segment Analysis by Type3.1 Global Neurological Biomarkers Market by Type
3.1.1 Proteomics
3.1.2 Genomics
3.1.3 Imaging
3.1.4 Bioinformatics
3.1.5 Others3.2 Global Neurological Biomarkers Sales and Market Share by Type (2014-2019)
3.3 Global Neurological Biomarkers Revenue and Market Share by Type (2014-2019)
3.4 Global Neurological Biomarkers Average Price by Type (2014-2019)
3.5 Leading Players of Neurological Biomarkers by Type in 2019
3.6 Conclusion of Segment by Type
Chapter 4 Neurological Biomarkers Market Segment Analysis by Application4.1 Global Neurological Biomarkers Market by Application
4.1.1 Diagnostics
4.1.2 Drug Discovery
4.1.3 Personalized Medicine
4.1.4 Others4.2 Global Neurological Biomarkers Sales and Market Share by Application (2014-2019)
4.3 Leading Consumers of Neurological Biomarkers by Application in 2019
4.4 Conclusion of Segment by Application
Chapter 5 Neurological Biomarkers Market Segment Analysis by Sales Channel5.1 Global Neurological Biomarkers Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel5.2 Global Neurological Biomarkers Sales and Market Share by Sales Channel (2014-2019)
5.3 Leading Distributors/Dealers of Neurological Biomarkers by Sales Channel in 2019
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Neurological Biomarkers Market Segment Analysis by Region6.1 Global Neurological Biomarkers Market Size and CAGR by Region (2014-2029)
6.2 Global Neurological Biomarkers Sales and Market Share by Region (2014-2019)
6.3 Global Neurological Biomarkers Revenue and Market Share by Region (2014-2019)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Neurological Biomarkers Market Share by Type
6.4.3 North America Neurological Biomarkers Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Neurological Biomarkers Market Share by Type
6.5.3 Europe Neurological Biomarkers Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Neurological Biomarkers Market Share by Type
6.6.3 Asia-Pacific Neurological Biomarkers Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Neurological Biomarkers Market Share by Type
6.7.3 South America Neurological Biomarkers Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Neurological Biomarkers Market Share by Type
6.8.3 Middle East & Africa Neurological Biomarkers Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Neurological Biomarkers Players7.1 Merck
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 COVID-19 Impact on Merck7.2 Quest Diagnostics
7.3 Abbott
7.4 Roche
7.5 Illumina
7.6 Bio-Rad Laboratories
7.7 Qiagen
7.8 Myriad Rbm
7.9 Cisbio Bioassays7.10 Athena Diagnostics
7.11 Bgi
7.12 Wuxi App
7.13 Aepodia
7.14 Proteome Sciences
7.15 Genewiz
Chapter 8 Upstream and Downstream Analysis of Neurological Biomarkers8.1 Industrial Chain of Neurological Biomarkers
8.2 Upstream of Neurological Biomarkers
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process8.3 Downstream of Neurological Biomarkers
8.3.1 Leading Distributors/Dealers of Neurological Biomarkers
8.3.2 Leading Consumers of Neurological Biomarkers
Chapter 9 Development Trend of Neurological Biomarkers (2020-2029)9.1 Global Neurological Biomarkers Market Size (Sales and Revenue) Forecast (2020-2029)
9.2 Global Neurological Biomarkers Market Size and CAGR Forecast by Region (2020-2029)
9.3 Global Neurological Biomarkers Market Size and CAGR Forecast by Type (2020-2029)
9.4 Global Neurological Biomarkers Market Size and CAGR Forecast by Application (2020-2029)
9.5 Global Neurological Biomarkers Market Size and CAGR Forecast by Sales Channel (2020-2029)
Chapter 10 Appendix10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure Neurological Biomarkers Example
Figure Global Neurological Biomarkers Revenue (Million $) Status and Outlook (2014-2029)
Figure Global Neurological Biomarkers Revenue (Million $) Comparison by Region (2014-2029)
Figure Global Neurological Biomarkers Sales Comparison by Type (2014-2029)
Figure Global Neurological Biomarkers Sales Comparison by Application (2014-2029)
Figure Global Neurological Biomarkers Sales Comparison by Sales Channel (2014-2029)
Table Global Neurological Biomarkers Sales by Player (2017-2019)
Table Global Neurological Biomarkers Sales Market Share by Player (2017-2019)
Figure Global Neurological Biomarkers Sales Market Share by Player in 2019
Table Global Neurological Biomarkers Revenue (Million $) by Player (2017-2019)
Table Global Neurological Biomarkers Revenue Market Share by Player (2017-2019)
Figure Global Neurological Biomarkers Revenue Market Share by Player in 2019
Table Global Neurological Biomarkers Average Price by Player (2017-2019)
Figure Global Neurological Biomarkers Average Price by Player in 2019
Figure Global Neurological Biomarkers Players Competition Situation – Top 5 Players’ Revenue Market Share in 2017
Figure Global Neurological Biomarkers Players Competition Trends – Top 5 Players’ Revenue Market Share in 2019
Figure Example of Proteomics
Figure Global Proteomics Sales and Growth Rate (2014-2019)
Figure Example of Genomics
Figure Global Genomics Sales and Growth Rate (2014-2019)
Figure Example of Imaging
Figure Global Imaging Sales and Growth Rate (2014-2019)
Figure Example of Bioinformatics
Figure Global Bioinformatics Sales and Growth Rate (2014-2019)
Figure Example of Others
Figure Global Others Sales and Growth Rate (2014-2019)
Table Global Neurological Biomarkers Sales by Type (2014-2019)
Table Global Neurological Biomarkers Sales Market Share by Type (2014-2019)
Figure Global Neurological Biomarkers Sales Market Share by Type in 2019
Table Global Neurological Biomarkers Revenue (Million $) by Type (2014-2019)
Table Global Neurological Biomarkers Revenue Market Share by Type (2014-2019)
Figure Global Neurological Biomarkers Revenue Market Share by Type in 2019
Table Global Neurological Biomarkers Average Price by Type (2014-2019)
Figure Global Neurological Biomarkers Average Price by Type in 2019
Table Leading Players of Neurological Biomarkers by Type in 2019
Figure Example of Diagnostics
Figure Global Neurological Biomarkers for Diagnostics Sales and Growth Rate (2014-2019)
Figure Example of Drug Discovery
Figure Global Neurological Biomarkers for Drug Discovery Sales and Growth Rate (2014-2019)
Figure Example of Personalized Medicine
Figure Global Neurological Biomarkers for Personalized Medicine Sales and Growth Rate (2014-2019)
Figure Example of Others
Figure Global Neurological Biomarkers for Others Sales and Growth Rate (2014-2019)
Table Global Neurological Biomarkers Sales by Application (2014-2019)
Table Global Neurological Biomarkers Sales Market Share by Application (2014-2019)
Figure Global Neurological Biomarkers Sales Market Share by Application in 2019
Table Leading Consumers of Neurological Biomarkers by Application in 2019
Figure Example of Direct Channel
Figure Global Neurological Biomarkers for Direct Channel Sales and Growth Rate (2014-2019)
Figure Example of Distribution Channel
Figure Global Neurological Biomarkers for Distribution Channel Sales and Growth Rate (2014-2019)
Table Global Neurological Biomarkers Sales by Sales Channel (2014-2019)
Table Global Neurological Biomarkers Sales Market Share by Sales Channel (2014-2019)
Figure Global Neurological Biomarkers Sales Market Share by Sales Channel in 2019
Table Leading Distributors/Dealers of Neurological Biomarkers by Sales Channel in 2019
Table Global Neurological Biomarkers Market Size and CAGR by Region (2014-2029)
Table Global Neurological Biomarkers Sales by Region (2014-2019)
Table Global Neurological Biomarkers Sales Market Share by Region (2014-2019)
Figure Global Neurological Biomarkers Sales Market Share by Region in 2019
Table Global Neurological Biomarkers Revenue (Million $) by Region (2014-2019)
Table Global Neurological Biomarkers Revenue Market Share by Region (2014-2019)
Figure Global Neurological Biomarkers Revenue Market Share by Region in 2019
Table North America Neurological Biomarkers Sales by Country (2014-2019)
Figure North America Neurological Biomarkers Sales Market Share by Country (2014-2019)
Table North America Neurological Biomarkers Revenue by Country (2014-2019)
Figure North America Neurological Biomarkers Revenue Market Share by Country (2014-2019)
Figure North America Neurological Biomarkers Sales Market Share by Type in 2019
Figure North America Neurological Biomarkers Sales Market Share by Application in 2019
Figure United States Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure United States Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure Canada Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure Canada Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure Mexico Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure Mexico Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Table Europe Neurological Biomarkers Sales by Country (2014-2019)
Figure Europe Neurological Biomarkers Sales Market Share by Country (2014-2019)
Table Europe Neurological Biomarkers Revenue by Country (2014-2019)
Figure Europe Neurological Biomarkers Revenue Market Share by Country (2014-2019)
Figure Europe Neurological Biomarkers Sales Market Share by Type in 2019
Figure Europe Neurological Biomarkers Sales Market Share by Application in 2019
Figure Germany Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure Germany Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure UK Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure UK Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure France Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure France Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure Italy Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure Italy Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure Russia Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure Russia Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure Spain Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure Spain Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Table Asia-Pacific Neurological Biomarkers Sales by Country (2014-2019)
Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Country (2014-2019)
Table Asia-Pacific Neurological Biomarkers Revenue by Country (2014-2019)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Country (2014-2019)
Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Type in 2019
Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Application in 2019
Figure China Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure China Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure Japan Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure Japan Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure Korea Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure Korea Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure India Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure India Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure Southeast Asia Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure Southeast Asia Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure Australia Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure Australia Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Table South America Neurological Biomarkers Sales by Country (2014-2019)
Figure South America Neurological Biomarkers Sales Market Share by Country (2014-2019)
Table South America Neurological Biomarkers Revenue by Country (2014-2019)
Figure South America Neurological Biomarkers Revenue Market Share by Country (2014-2019)
Figure South America Neurological Biomarkers Sales Market Share by Type in 2019
Figure South America Neurological Biomarkers Sales Market Share by Application in 2019
Figure Brazil Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure Brazil Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure Argentina Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure Argentina Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure Colombia Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure Colombia Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Table Middle East & Africa Neurological Biomarkers Sales by Country (2014-2019)
Figure Middle East & Africa Neurological Biomarkers Sales Market Share by Country (2014-2019)
Table Middle East & Africa Neurological Biomarkers Revenue by Country (2014-2019)
Figure Middle East & Africa Neurological Biomarkers Revenue Market Share by Country (2014-2019)
Figure Middle East & Africa Neurological Biomarkers Sales Market Share by Type in 2019
Figure Middle East & Africa Neurological Biomarkers Sales Market Share by Application in 2019
Figure UAE Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure UAE Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure Saudi Arabia Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure Saudi Arabia Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Figure South Africa Neurological Biomarkers Sales and Growth Rate (2014-2019)
Figure South Africa Neurological Biomarkers Revenue (Million $) and Growth Rate (2014-2019)
Table Company Snapshot of Merck
Table Neurological Biomarkers Introduction of Merck
Table Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share of Merck (2017-2019)
Table Industrial Chain of Neurological Biomarkers
Table Manufacturing Cost Structure of Neurological Biomarkers
Table General Manufacturing Process of Neurological Biomarkers
Table Leading Distributors/Dealers of Neurological Biomarkers
Table Leading Consumers of Neurological Biomarkers
Figure Global Neurological Biomarkers Sales and Growth Rate Forecast (2020-2029)
Figure Global Neurological Biomarkers Revenue and Growth Rate Forecast (2020-2029)
Table Global Neurological Biomarkers Market Size and CAGR Forecast by Region (2020-2029)
Table Global Neurological Biomarkers Market Size and CAGR Forecast by Type (2020-2029)
Table Global Neurological Biomarkers Market Size and CAGR Forecast by Application (2020-2029)
Table Global Neurological Biomarkers Market Size and CAGR Forecast by Sales Channel (2020-2029)
-
The Report on Global Neurological Biomarkers Market by Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
According to the report, the Report on Global Neurological Biomarkers Market by Industry will grow to USD XXX Million by 2029, with a YY% CAGR.
Yes, the add-on segmentation is available in the premium customised version of the Report on Global Neurological Biomarkers Market by Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.
The Report on Global Neurological Biomarkers Market by study focuses on shifting market dynamics, geopolitical and regulatory regulations, and key players' strategies to carefully analyze demand at risk across multiple industry categories.
